908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the U.S. Border Patrol selected the MX908® – a handheld, battery-powered, mass spectrometry device – to standardize its trace drug detection at 20 field locations across the U.S. borders, from North to South and in the Caribbean. The U.S. Border Patrol purchased more than 60 MX908 units, which are designed for rapid analysis of vapor, liquid and solid materials of unknown identity, to prevent drug smuggling and to work with local and state law enforcement in support of its counter drug mission.
Company profile
Ticker
MASS
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
908 Devices Securities Corporation • 908 Devices GmbH • 908 Devices (Shanghai) Technology Co., Ltd ...
IRS number
454524096
MASS stock data
Latest filings (excl ownership)
10-Q
2023 Q1
Quarterly report
9 May 23
8-K
908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook
9 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
S-8
Registration of securities for employees
15 Mar 23
10-K
2022 FY
Annual report
15 Mar 23
8-K
908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook
7 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook
14 Nov 22
Transcripts
MASS
Earnings call transcript
2022 Q4
7 Mar 23
MASS
Earnings call transcript
2022 Q3
14 Nov 22
MASS
Earnings call transcript
2022 Q2
9 Aug 22
MASS
Earnings call transcript
2022 Q1
10 May 22
MASS
Earnings call transcript
2021 Q4
8 Mar 22
MASS
Earnings call transcript
2021 Q3
6 Nov 21
MASS
Earnings call transcript
2021 Q2
7 Aug 21
MASS
Earnings call transcript
2021 Q1
13 May 21
MASS
Earnings call transcript
2020 Q4
30 Mar 21
Latest ownership filings
4
Kevin J. Knopp
5 Jun 23
4
Christopher D. Brown
25 May 23
4
Kevin J. Knopp
25 May 23
144
Notice of proposed sale of securities
23 May 23
4
Joseph H. IV Griffith
23 Mar 23
4
Christopher D. Brown
16 Mar 23
4
Joseph H. IV Griffith
16 Mar 23
4
Michael S. Turner
16 Mar 23
4
Kevin J. Knopp
16 Mar 23
4
Anthony Hunt
7 Mar 23
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 161.39 mm | 161.39 mm | 161.39 mm | 161.39 mm | 161.39 mm | 161.39 mm |
| Cash burn (monthly) | 9.07 mm | 5.15 mm | 4.34 mm | 3.24 mm | 3.55 mm | 2.59 mm |
| Cash used (since last report) | 20.95 mm | 11.90 mm | 10.02 mm | 7.49 mm | 8.20 mm | 5.99 mm |
| Cash remaining | 140.43 mm | 149.49 mm | 151.36 mm | 153.90 mm | 153.19 mm | 155.40 mm |
| Runway (months of cash) | 15.5 | 29.0 | 34.9 | 47.5 | 43.2 | 59.9 |
Institutional ownership, Q4 2022
94.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 96 |
| Opened positions | 24 |
| Closed positions | 12 |
| Increased positions | 28 |
| Reduced positions | 28 |
| 13F shares | Current |
|---|---|
| Total value | 152.02 bn |
| Total shares | 30.24 mm |
| Total puts | 5.20 k |
| Total calls | 90.70 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Arch Venture Fund VII | 5.73 mm | $0.00 |
| ARK Investment Management | 3.69 mm | $28.11 bn |
| Alger Associates | 2.81 mm | $0.00 |
| Fred Alger Management | 2.80 mm | $21.37 bn |
| Eventide Asset Managment | 2.23 mm | $17.00 bn |
| BLK Blackrock | 1.76 mm | $13.44 bn |
| Vanguard | 1.50 mm | $11.41 bn |
| AMP Ameriprise Financial | 1.25 mm | $9.52 bn |
| Granahan Investment Management | 1.10 mm | $8.42 bn |
| Iron Triangle Partners | 874.73 k | $6.67 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Jun 23 | Kevin J. Knopp | Common Stock | Option exercise | Acquire M | No | No | 1.75 | 28,500 | 49.88 k | 396,348 |
| 5 Jun 23 | Kevin J. Knopp | Stock Option (option to buy) Common Stock | Option exercise | Dispose M | No | No | 1.75 | 28,500 | 49.88 k | 94,418 |
| 23 May 23 | Kevin J. Knopp | Common Stock, par value $0.001 | Sell | Dispose S | No | Yes | 10.12 | 60,000 | 607.20 k | 367,848 |
| 23 May 23 | Christopher D. Brown | Common Stock, par value $0.001 | Sell | Dispose S | No | Yes | 10.02 | 10,000 | 100.20 k | 892,375 |
| 22 Mar 23 | Joseph H. IV Griffith | Common Stock, par value $0.001 | Option exercise | Acquire M | No | No | 1.58 | 5,000 | 7.90 k | 96,580 |
| 22 Mar 23 | Joseph H. IV Griffith | Stock Option (option to buy) Common Stock, par value $0.001 | Option exercise | Dispose M | No | No | 1.58 | 5,000 | 7.90 k | 13,437 |
| 2 Mar 23 | Anthony Hunt | Common Stock, par value $0.001 | Option exercise | Acquire M | No | No | 0 | 2,058 | 0.00 | 2,058 |
| 2 Mar 23 | Anthony Hunt | RSU Common Stock, par value $0.001 | Option exercise | Dispose M | No | No | 0 | 2,058 | 0.00 | 4,115 |
News
12 Information Technology Stocks Moving In Tuesday's Intraday Session
23 May 23
908 Devices Q1 EPS $(0.39) Misses $(0.36) Estimate, Sales $9.49M Beat $8.65M Estimate
9 May 23
Earnings Scheduled For May 9, 2023
9 May 23
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
23 Mar 23
Stocks That Hit 52-Week Lows On Monday
20 Mar 23
Press releases
908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference
30 May 23
908 Devices to Participate in the William Blair 43rd Annual Growth Stock Conference
23 May 23
908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer
4 May 23
Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices' REBEL At-line Analyzer
26 Apr 23
908 Devices to Report First Quarter Financial Results on May 9, 2023
25 Apr 23